Property:RefPreview
From GxPlex
Auto-derived 200-character preview of this reference's content, used in Document pages' References list.
C
CIOMS CIOMS - International Ethical Guidelines for Biomedical Research Involving Human Subjects 2016 Page 23 +
Guideline 4: Individual informed consent
[...]
Commentary on Guideline 4
[...]
Renewing consent.
When material changes occur in the conditions or the… +
I
Guidelines for Good Pharmacoepidemiology Practices (GPP)
International Society for Pharmacoepidemiology (ISPE)
https://www.pharmacoepi.org/resources/… +
G
HRA (England) website: https://www.hra.nhs.uk/approvals-amendments/managing-your-approval/ending-your-project/
Final report on the research
Once you … +
I
I.6.3 Non-interventional clinical investigation
[…]… +
ICH guideline E8 (R1) on general considerations for clinical studies… +
II. PRINCIPLES OF ICH GCP
[...]
1. Clinical trials should be conducted in accordance with the ethical principles that have their origin in the Declara… +
II. Protocol Development
[...]… +
U
USA Informed Consent - FDA Guidance for IRBs, Clinical Investigators, and Sponsors Aug-2023 II. Introduction +
II. SUMMARY OF THE CONSENT PROCESS
To many, the term informed consent is mistakenly viewed as synonymous with obtaining a subject’s signature on the c… +
USA Informed Consent - FDA Guidance for IRBs, Clinical Investigators, and Sponsors Aug-2023 II. Advertising-001 +
II. SUMMARY OF THE CONSENT PROCESS
[…]
FDA considers advertising used to recruit subjects into the clinical trial to be the start of the ongoing conse… +
USA Informed Consent - FDA Guidance for IRBs, Clinical Investigators, and Sponsors Aug-2023 II. Advertising-002 +
II. SUMMARY OF THE CONSENT PROCESS
[…]
FDA considers advertising used to recruit subjects into the clinical trial to be the start of the ongoing conse… +
USA FDA Guidance for Industry Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects Oct-2009 III. B. +
III. CLARIFICATION OF CERTAIN INVESTIGATOR RESPONSIBILITIES
[...]
B. Protecting the Rights, Safety, and Welfare of Study Subjects
Investigators are re… +
USA FDA Guidance for Industry Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects Oct-2009 III. A. +
III. CLARIFICATION OF CERTAIN INVESTIGATOR RESPONSIBILITIES
This section of the guidance clarifies the investigator’s responsibility to supervise the… +
III. Electronic Source Data
[...]
2. Source Data Capture
Data can be entered into the eCRF either manually or electronically as described below.
a. Di… +
III. Electronic Source Data
[…]
4. Modifications and Corrections
Only a clinical investigator(s) or delegated clinical study staff should perform modi… +
III. FDA INFORMED CONSENT REQUIREMENTS AND DISCUSSION
[…]
E. Documentation of Informed Consent
[...]
b. Short Form
An IRB may approve a short form to … +
III. GENERAL PRINCIPLES
[...]
C. Source documents should be retained to enable a reconstruction and evaluation of the trial.
D. When original observat… +
USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 III - IV. +
III. OVERVIEW OF MONITORING METHODS
A. On-Site and Centralized Monitoring
1. On-Site Monitoring
2. Centralized Monitoring
B. Examples of Alternative M… +
USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 III B. 3. +
III. OVERVIEW OF MONITORING METHODS
B. Examples of Alternative Monitoring Techniques
[…]
3. Source Data Verification and Corroboration
The sponsor sho… +
I
III. TRIAL DESIGN CONSIDERATIONS
3.1 Design Configuration
3.1.1 Parallel Group Design
[…]
3.1.2 Crossover Design
[…]
3.1.3 Factorial Designs
[…]
3.2 M… +
IMDRF: International Medical Device Regulators Forum ; Global Harmonization Task Force (GHTF)
GHTF Study Group 4 – Auditing
https://www.imdrf.org/doc… +
